Commentaries by CPNP
- Comments to Senate Finance Committee on Opioid Crisis: February 16, 2018
- Comments to Senate HELP Committee on MAT: February 7, 2018
- MHLG supports Sen. Warren's-Rep Kennedy Behavioral Health Coverage Transparency Act of 2018: January 26, 2018
- CMS-Innovation Center New Direction: November 20, 2017
- Support of HR 3991-DATA Waiver for Expanded MAT Access: October 25, 2017
- Comments to Commission on Opioid Epidemic: October 3, 2017
- Comments to Behavioral Health Payment and Care Delivery Innovation Summit: August 24, 2017
- Comments to Interdepartmental Serious Mental Illness Coordinating Committee: August 24, 2017
- Comments on Proposed Rule Implementing the Hospital Inpatient Prospective Payment (IPPS) for FY 2018: June 13, 2017
- CPNP Comments on Medicare Advantage and Part D Advance Notice and Draft Call Letter: March 1, 2017
Previous Commentaries: 2013-2016
- Medicare Payment Policies-Physicians Comments to CMS: August 14, 2016
- Joint Pharm Org Comments to CMS on MACRA Proposed Rule: June 27, 2016
- ClozapineREMS Letter to FDA: June 16, 2016
- Patient Stakeholders Oppose MedPAC Recommendation to Undermine Medicares Protected Classes: June 15, 2016
- CPNP Urges Inclusion of Psychiatric Pharmacists in Letter to the Editor: June 12, 2016
- CPNP/ACCP Coalition Submits Comments to Hearing Focused on “Legislation to Improve and Sustain the Medicare Program": June 6, 2016
- CPNP Comments on the Better Care, Lower Cost Act: March 11, 2016
- CPNP Comments to Sentate Finance Chronic Care Committee: January 22, 2016
- CPNP Comments on Medicare Part D Medication Therapy Management Program: October 21, 2015
- CPNP Comments on International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Ketamine and Nine Other Substances: October 15, 2015
- Letter to FDA Regarding Inclusion of Board Certified Psychiatric Pharmacists into the Clozapine REMS Enrollment Form: September 29, 2015
- CPNP Comments on Reform of Requirements for Long-Term Care Facilities: September 14, 2015
- Senate Committee comments on Chronc Care: June 19, 2015
- May 2015-ACCP CPNP Comments Senate Finance Committee Hearing A Pathway to Improving Care for Medicare Patients with Chronic Conditions: May 14, 2015
- CPNP Response-USP General Chapter 800 Hazardous Drugs – Handling in Healthcare Settings: May 4. 2015
- CPNP Response-NIOSH Hazardous Drugs List for Classification of a Medication as Hazardous: June 17, 2014
- Letter to Congressman Tim Murphy: April 14, 2014
- PAPCC response letter to APhA: March 10, 2014
- Letter to Membership on PAPCC: March 10, 2014
- CMS Comment Letter-MTM Expansion-Drug Class Limitations: March 7, 2014
- Better Care Act Response-Sen Wyden: March 3, 2014
- CPNP Mental Health Improvement Response Letter: September 13, 2013
One of CPNP’s primary strategies is to partner with others in the health professions through coalitions. This collective work allows us to advocate for legislation and regulation that is favorable toward the profession and the patients we serve but with a much bigger, more powerful voice. Partnering with coalitions:
- Builds CPNP’s profile within the pharmacy and mental health advocacy community.
- Allows CPNP to be a participant in policy discussions.
- Enhances and showcases CPNP's patient advocacy efforts.
CPNP participates in and supports the work of the following coalition partners:
The Health Professions and Nursing Education Coalition (HPNEC) is an informal alliance of more than 60 organizations representing a variety of schools, programs, health professionals and students dedicated to educating professional health personnel. Together, the members of HPNEC advocate for adequate and continued support for the health professions and nursing workforce development programs authorized under Titles VII and VIII of the Public Health Service Act. The members of the Coalition believe these programs are essential to the development and training of tomorrow's health professionals and are critical to providing continued health services to underserved and minority communities.
The Mental Health Liaison Group (MHLG) is a coalition of national organizations representing consumers, family members, mental health and addiction providers, advocates, payers and other stakeholders committed to strengthening Americans’ access to mental health and addiction care. As trusted leaders in the field, our 60+ member organizations are dedicated to elevating the national conversation around mental health and addiction. Together, we work to advance federal policies that support prevention, early intervention, treatment and recovery services and supports.
The mission of the Patient Access to Pharmacists’ Care Coalition (PAPCC) is to develop and help enact a federal policy proposal that would enable Medicare beneficiary access to, and payment for, Medicare Part B services by state-licensed pharmacists in medically underserved communities. Our primary goal is to improve medically underserved seniors’ access to pharmacists’ services consistent with state scope of practice laws and regulations.